Department of Blood Transfusion, Affiliated Hospital of Medical College, Qingdao University, Qingdao, China.
Department of Operating Room, Affiliated Hospital of Medical College, Qingdao University, Qingdao, China.
Saudi J Gastroenterol. 2019 May-Jun;25(3):145-151. doi: 10.4103/sjg.SJG_465_18.
Long noncoding RNAs (lncRNAs) are a new class of regulators. LncRNAs are defined as endogenous transcribed RNA molecules with transcript length of >200 nt. Accumulating evidence has shown that lncRNAs are involved in many physiological processes such as cell cycle regulation, cell apoptosis and survival, cancer migration and metabolism. However, the biological and molecular mechanisms of lncRNAs in pancreatic cancer are still unclear. Recent studies have reported that many lncRNAs are dysregulated in pancreatic cancer and closely associated with tumorigenesis, diagnosis and prognosis. In this review, we described the regulation and functional role of lncRNAs and the potential underlying mechanism involved in pancreatic cancer, outlined the roles of lncRNA in pancreatic cancer, and discussed the potential possibility of lncRNAs as therapeutic targets in clinical practice. Moreover, the potential of lncRNAs used as sensitive biomarkers for diagnosis, prognosis and prediction of response to therapy in pancreatic cancer will also be discussed.
长链非编码 RNA(lncRNAs)是一类新的调控因子。lncRNAs 的定义为转录本长度大于 200nt 的内源性转录 RNA 分子。越来越多的证据表明,lncRNAs 参与许多生理过程,如细胞周期调控、细胞凋亡和存活、癌症迁移和代谢。然而,lncRNAs 在胰腺癌中的生物学和分子机制尚不清楚。最近的研究表明,许多 lncRNAs 在胰腺癌中失调,与肿瘤发生、诊断和预后密切相关。在这篇综述中,我们描述了 lncRNAs 的调控和功能作用,以及涉及胰腺癌的潜在机制,概述了 lncRNA 在胰腺癌中的作用,并讨论了 lncRNAs 作为临床治疗靶点的潜在可能性。此外,还将讨论 lncRNAs 作为胰腺癌诊断、预后和预测治疗反应的敏感生物标志物的潜力。